Soroprevalência de doenças infecciosas em doadores de sangue do hemocentro regional de Cruz Alta-Rio Grande do Sul
Introduction: Clinical and serological screening of blood donors is an essential strategy to prevent transmission of infectious agents during blood transfusion.Objective: To determine the seroprevalence of infectious diseases in blood donors at the Blood Center of Cruz Alta. Method: Prospective cros...
| Autores: | , , , |
|---|---|
| Formato: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2015 |
| País: | Brasil |
| Recursos: | Universidade Federal do Rio Grande do Sul (UFRGS) |
| Repositorio: | Clinical and Biomedical Research |
| Idioma: | portugués |
| OAI Identifier: | oai:seer.ufrgs.br:article/58832 |
| Acesso em linha: | https://seer.ufrgs.br/index.php/hcpa/article/view/58832 |
| Access Level: | acceso abierto |
| Palavra-chave: | Doadores de sangue. Doenças Transmissíveis. Bancos de Sangue. Banco de sangue |
| Resumo: | Introduction: Clinical and serological screening of blood donors is an essential strategy to prevent transmission of infectious agents during blood transfusion.Objective: To determine the seroprevalence of infectious diseases in blood donors at the Blood Center of Cruz Alta. Method: Prospective cross-sectional study conducted at the Blood Center of Cruz Alta, Rio Grande do Sul, from January 2013 to June 2014. Results: 6139 donations were made during the study period, 280 (4,56%) of which were considered unfit for presenting some positive serological marker. The average age of unfit donors was 38 years, and 171 (61.1%) donors were male. Regarding the serological markers, 151 (46.1%) donors were positive for anti-HBc, 15 (5.4%) for HBsAg, 21 (7.5%) for anti-HCV, 15 (5.4%) for HIV, 19 (6.8%) for HIV-Ag AC, 6 (2.1%) for HTLV-I /II, 64 (22.9%) for Chagas disease, and 37 (13.2%) for syphilis (VDRL).Conclusion: The results show the importance of serological screening in order to ensure transfusion safety and prevent infection of individuals who need blood transfusions. |
|---|